Research Article

Anti-ICOSL New Antigen Receptor Domains Inhibit T Cell Proliferation and Reduce the Development of Inflammation in the Collagen-Induced Mouse Model of Rheumatoid Arthritis

Table 1


ParameterIntravenous doseSubcutaneous dose

Clearance (ml/h/kg)17.128.1
Half-life (h)5238
AUC (hμg/ml)234142
Bioavailability61%